Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

Clinical trial NCT02566421 · TERMINATED

Trial details

NCT number: NCT02566421
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Neoplasm Recurrent Neoplasm Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Unresectable Malignant Neoplasm

Start date: 2015-10-01
Primary completion: 2017-08-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.